Mereo BioPharma enters securities agreement with institutional investor
19th Feb 2020 07:38
(Sharecast News) - Mereo BioPharma Group has entered into a securities purchase agreement with a new US-based institutional healthcare investor, it announced on Wednesday.
Read moreMereo BioPharma releases 'encouraging' data from setrusumab study
30th May 2019 10:40
(Sharecast News) - Clinical stage biopharmaceutical company Mereo BioPharma Group announced encouraging six-month data from the open label arm of its phase 2b dose-ranging clinical study in adults with type I, III or IV osteogenesis imperfecta (OI) treated with BPS-804 ('setrusumab'), or the 'ASTEROID' study, on Thursday.
Read moreMereo BioPharma merger with OncoMed moves closer
15th Mar 2019 15:16
(Sharecast News) - Clinical-stage biopharmaceutical company Mereo BioPharma Group updated the market on its proposed combination with OncoMed Pharmaceuticals on Friday, which it said should close in the second quarter of 2019.
Read more